Product Launch

New clinical data suggests Cullinan Therapeutics' cancer-fighting tech could offer durable, treatment-free remission for severe RA and lupus patients.

Organon's FDA nod for TOFIDENCE in critical care isn't just a clinical win. It's a calculated move to capture market share and challenge high-cost biologics.

The asset manager's May report reveals $3.3B in net inflows, driven by a major target date fund win, underscoring its market resilience and leadership.

A junior miner revives a historic Utah uranium district, blending old data with new tech. Is this a savvy play for the nuclear boom or a speculative gamble?

A new trilateral framework from NEMA, ASHRAE, and PNNL provides a crucial blueprint for building the next generation of efficient, resilient AI data centers.

Latest drill results from Brunswick Exploration’s Anatacau project reveal major lithium potential, sparking comparisons to its flagship Mirage asset.

A Texas university is building a city-within-a-city. Is this a bold new model for institutional survival or a high-stakes gamble on real estate?

Centro and Sun Life's new API link isn't just a tech update. It’s a signal of a massive shift in a legacy industry, replacing manual processes with speed.

U.S. Gold's latest move at its CK Gold project is no mere update; it's a signal of intent to redefine the project's scale and chase historical riches.

At VidCon 2026, Amaze Holdings pitched a future where creators are CEOs. But with staggering losses and a 'going concern' notice, can it build the machine before it runs out of cash?

As attackers arm themselves with AI, a new breed of defense is emerging. Zimperium's recent leadership nod reveals a critical shift to embedded AI security.

Autonomous AI agents are multiplying in corporate networks, unseen and ungoverned. A new security category, 'AI Agent Governance,' aims to stop a crisis.

After a 60-year battle against a defunct freeway, South Pasadena is selling eight historic homes, offering a rare chance at ownership in a tight market.

A new study reveals the biggest planning mistake in enterprise IT is rigid strategy. For companies betting on digital transformation, adaptability is now survival.

A new study finds 71% of data transformations pivot mid-project. This exposes the fatal flaw in rigid planning and makes the case for adaptive strategies.

Questex's Fierce Biotech is launching a UK event, but this is more than expansion. It’s a calculated bet on London's future as a biotech superpower.

Logitech's new Mobi Fold isn't just a clever gadget. It's a strategic assault on the trackpad, aiming to close the productivity gap for hybrid professionals.

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

Japanese artist Takuma Tanaka's journey from law to canvas culminates in a Miami exhibition that channels Bruce Lee's wisdom to challenge modern overthinking.

Pollo AI's new Commerce Studio promises to slash product visual costs for sellers. But as AI automates the photo shoot, it raises critical questions about creative jobs and consumer trust.